Marina Boccardi - Epidemiology

Author Information

Marina Boccardi is a prominent researcher affiliated with the LANE - Laboratory of Alzheimer's Neuroimaging & Epidemiology at IRCCS S. Giovanni di Dio, Fatebenefratelli in Brescia, Italy. Her work primarily focuses on Alzheimer's disease, with a particular emphasis on neuroimaging, fluid biomarkers, and the implementation of innovative diagnostic methods in dementia research.

Research Contributions

Marina Boccardi has made significant contributions to the field of dementia and Alzheimer's disease research. Her work includes exploring the clinical validity of advanced imaging techniques and biomarkers, such as tau PET tracers, in the diagnosis of Alzheimer's disease. She has also contributed to the development of strategic biomarker roadmaps and has investigated the impact of participatory dementia research on researchers. Her research aims to advance the understanding and diagnosis of neurocognitive disorders, particularly in diverse and immigrant populations.

Aliases

Marina Boccardi is also known by the aliases M Boccardi and M. Boccardi.

Publication and Citation Metrics

Metric	Value
Total Paper Count	209
Total Citation Count	5883
H-index	42

Publications:

Answer to "Social cognition assessment for mild neurocognitive disorders".

DOI: 10.1002/alz.12664

Year: 2022

Clinical research in dementia: A perspective on implementing innovation.

DOI: 10.1002/alz.12622

Year: 2022

The impact of participatory dementia research on researchers: A systematic review

DOI: 10.1177/14713012211067020

Year: 2022

Molecular imaging and fluid biomarkers of Alzheimer’s disease neuropathology: an opportunity for integrated diagnostics

DOI: 10.1007/s00259-020-05116-y

Year: 2021

The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

DOI: 10.1007/s00259-020-05120-2

Year: 2021

Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

DOI: 10.1007/s00259-020-05156-4

Year: 2021

Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

DOI: 10.1007/s00259-021-05277-4

Year: 2021

Diagnosing foreign patients in Europe: An EADC‐ISTAART study

DOI: 10.1002/alz.049338

Year: 2021

Distance assessment of cognitive deficits in older immigrants

DOI: 10.1002/alz.049315

Year: 2021

Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

DOI: 10.1007/s00259-021-05549-z

Year: 2021

What Role Do Police Reports Play in Policy Making?

What role do molecular techniques play in epidemiology?

Why is Risk Management Important?

What Are Cosmetic Interventions?

What are the Trends in Opioid Overdose?

How Does Gene Therapy Work for Hemophilia?

Why are community-based approaches important?

How are Opportunistic Infections Transmitted?

What Types of Surfaces Are Most Prone to Contamination?

What are the Limitations of the Glasgow Coma Scale?

Partnered Content Networks

Relevant Topics